Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-06

Clinical Trial Update: Effect of Oral Isotretinoin on The Level of SerumYKL40 in Acne Vulgaris Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effect of oral isotretinoin on serum YKL-40 levels in acne vulgaris patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Alshimaa Abbas Mohamed Ebrahim | Conditions: Acne Vulgaris | Phase 4 | Status: UNKNOWN